A randomized, placebo-controlled trial of a combination of Lactobacillus rhamnosus and Bifidobacterium lactis Bb12 in schizophrenia did not change PANSS scores over the course of the 14 week trial (87), though a trend increase in plasma BDNF was observed (88). Here, BDNF is linked to schizophrenia.